Skip to main content
OpenTrials
Completed

NCT Number: NCT00963287

Trial of Chinese Prescription on Ulcerative Colitis

The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription on Ulcerative Colitis.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Longhua hospital

Shanghai, Shanghai Municipality, 200032, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of ulcerative colitis
  • Male of female patients between 18-65 years old
  • Written informed consent

Exclusion criteria

  • Combine with malignant pathology on epithelial dysplasia of mucosa
  • Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease.
  • Pregnancy or breast feeding women, or unwilling to have contraception.

Treatment and study plan

bascial prescription plus or minus herbs depend on symptoms

Drug

Decoction ,two times a day

Primary outcomes

  1. Histopathological examination,enteroscopy,blood test,symptoms ,pulse tracings,tongue demonstration

    Time frame: 8 weeks

Secondary outcomes

  1. Indicates of liver and renal function

    Time frame: 8 weeks

Sponsors and collaborators

Lead sponsor

Shanghai University of Traditional Chinese Medicine

Other

Registry information

Important dates

Study start
2009
Primary completion
2011
Study completion
2011
First posted
Aug 21, 2009
Registry last updated
Apr 19, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.